Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!

CAR-T Target Proteins

CAR-T Target Proteins

Human EGFR/HER1 Protein

CAT#: CAR-T011

Keywords: Human; C-His-Avi; Expi293

Inquiry

FITC-Labeled Human EGFR VIII Protein

CAT#: CAR-T012

Keywords: Human; C-His-Avi; Expi293

Inquiry

PE-Labeled Human EGFR VIII Protein

CAT#: CAR-T013

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human FAP Protein

CAT#: CAR-T014

Keywords: Human; N-His; Expi293

Inquiry

Human FOLR1 Protein

CAT#: CAR-T015

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human GPC3/Glypican 3 Protein

CAT#: CAR-T016

Keywords: Human; C-His; Expi293

Inquiry

Human Her2/ErbB2 Protein

CAT#: CAR-T017

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human Her3/ErbB3 Protein

CAT#: CAR-T018

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human MSLN/Mesothelin Protein

CAT#: CAR-T019

Keywords: Human; C-His-Avi; Expi293

Inquiry

Human NKG2D/CD314 Protein

CAT#: CAR-T020

Keywords: Human; N-His-Avi; Expi293

Inquiry

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Alfa Cytology provides its clients with one-stop solutions to accelerate therapeutic discovery and development of brain tumors.

By Disease

Craniopharyngioma

Schwannoma (neuroma)

Pituitary Tumors

Choroid Plexus Tumors

By Molecule Type

Small Molecule Drug

Therapeutic Antibody

Immune Cell Therapy

Oncolytic Virotherapy

Vaccine Development

Contact Us

Copyright © 2024 Alfa Cytology. All rights reserved.